Singapore: Medgenics received a Notice of Allowance from the Japanese Patent and Trademark Office for key claims protec...
Singapore: Globally, the healthcare industry is in a state of accelerated evolution due to changing demographics and var...
Allied Healthcare Group's investment company, Coridon, which is led by Professor Ian Frazer, is in the process of develo...
Singapore: McCord Research provided grants worth $150,000 to Dr Tom Karagiannis and his team at the Baker IDI Heart and ...
Singapore: The Commonwealth Scientific and Industrial Research Organisation (CSIRO), which is Australia's leading scient...
Reforms in government policies and initiatives have helped in setting focus for bioscience companies, which has resulted...
Singapore: This year's AusBiotech Conference, which is scheduled to be held from October 30 to November 02, 2012 in Melb...
‎Singapore: ResMed, a sleep-disorder medical device company, has filed parallel legal actions in the International...
Singapore: Internationally-recognized experts in computing and atmospheric physics, developmental biology, organometalli...
Singapore: The IB Australian Bioscience Fund I has generated a unit price of $1.81 for every dollar invested four and a ...
Bangalore: Ms Vinita Gupta, CEO, Lupin Pharmaceuticals, was named the inaugural Ernst & Young US 2012 Family Busine...
Singapore: Patrys completed initial treatment of second group of three patients in its phase I/IIa PAT-SM6 multiple myel...
Singapore: Australia-based Novogen has acquired a novel drug technology that will be developed as a potentially major cl...
Singapore: Fibrotech Therapeutics, based in Melbourne has secured composition of matter patents in each jurisdiction rel...
Singapore: BGI, the world's largest genomics organization, and Griffith University in Australia have signed an agreement...
Singapore: Mayne Pharma has entered into a binding agreement to acquire Metrics, a privately-owned, US-based provider of...
Singapore: Genetic Technologies, a diagnostics company listed with the ASX and NASDAQ, has filed patent infringement sui...
Singapore: Australian drug delivery technology company Phosphagenics has appointed biotech industry veterans Mr Lawrence...
Singapore: Novogen has entered into a merger agreement with Kai Medical, whose business is focused on sleep apnea therap...
Integration of information and technology (IT) in healthcare services and translating the potential into better delivery...
Singapore: Australian scientists are helping to unravel the links between a person's brain chemistry, genes and their ri...
Singapore: Australia-based TGR BioSciences, a developer of advanced cell-based assay technologies, has signed a license ...
Australia-based SeerPharma, which offers international quality management and compliance experience, and advice to suppo...
Singapore: Patrys, a clinical stage biopharmaceutical company, has received a US patent for its lead product PAT-SM6. P...
Singapore: US-based medical technology company iSonea has collaborated with the Sydney-based digital health organization...
Singapore: DSM Pharmaceutical Products signed a biologics contract manufacturing agreement with Paranta Biosciences of ...
Singapore: Australian pharmaceutical company Pharmaxis is all set to launch Bronchitol for cystic fibrosis (CF) patients...
Singapore: Alchemia has completed enrollment of patients in a pivotal phase III clinical trial evaluating its lead prod...
Singapore: Australia's Starpharma has secured grant of $548,000 from Australian Research Council (ARC) Linkage grant. St...
Singapore: The fifth BioSpectrum Asia Pacific Awards 2013 were given away at a glittering ceremony at Hotel Fort Canning...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Exploit Technologies (ETPL), the technology transfer arm of the Agency for Science, Technology and Researc...
Singapore: The Australian government has imposed a temporary ban on sales of 19 synthetic drugs pursuant to the product ...
Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained i...
Singapore: Australia-based medical device company Nanosonics has appointed Cochlear senior executive Mr Michael Kavanagh...
Singapore: GI Dynamics has received full approval from the US FDA to commence a 25-site pivotal clinical trial of EndoB...
Singapore: Professor Richard Larkins has been appointed as the new director and chair of the Australian Synchrotron Hold...
Singapore: Australian company Bioxyne closed its 320-patient study, which was designed to evaluate the efficacy and safe...
Life sciences industry in the Asia Pacific recorded the double digit growth of 16.6 percent, reaching $128.26 billion in...
Singapore: Australia's Monash Institute of Medical Research scientists have found a protein in the female reproductive t...
Singapore: Regenerative medicine company Mesoblast has received positive results in a large animal model of rheumatoid a...
Singapore: Australian drug development company Biotron has completed the clinical stage of a landmark phase Ib/IIa proo...
In the legal case of Myriad Genetics vs Association for Molecular Pathology, the US Supreme Court's verdict unanimously ...
Singapore: UK-based contract organization TranScrip Partners launched its operations in Australia. TranScrip Partners su...
Singapore: Benitec Biopharma announced the acquisition of US-based RNA interference (RNAi) or gene silencing therapeuti...
Singapore: Australia-based Phylogica has successfully completed a major upgrade to its proprietary Phylomer libraries o...
Singapore: Sydney-based pharmaceutical company Phebra has inaugurated its $25 million manufacturing facilities at Lane C...
Singapore: Australian drug delivery technology company Phosphagenics has extended its collaboration with its high calib...
Singapore: Australia's DSM Pharmaceutical, the custom manufacturing and technology business of Royal DSM, has signed an ...
Singapore: Regular shots of influenza injections have the added benefit of reducing the risk of heart attacks in people ...
In 2011, the number of mergers and acquisitions in the life sciences field of Asia Pacific witnessed a fall. An indepen...
Singapore: Assistant Professor (Dr) Robert H I Andtbacka presented a summary of his ongoing study with Viralytics' Cavat...
The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...
Singapore: Australian firm Prima BioMed suggested several changes to its senior management and its board of directors, w...
Thanks to the Human Genome Project, scientists now have a set of tools that can be readily used to understand the comple...
Singapore: A new therapy to treat a common hospital superbug infection Clostridium difficile will soon be available to A...
Singapore: Australia based Admedus has received FDA clearance to market CardioCel in the US. CardioCel is the group's l...
Singapore: Biolife Science's strategy of targeting the tumour-associated antigen HER-2/NEU has been the focus of a recen...
Biologics manufacturers in Asia have to be more vigilant and give higher priority to product safety and product efficacy...
Singapore: The Supreme Court of Victoria, Australia, has ordered a meeting of Biota Holdings shareholders to consider an...
Singapore: Viralytics reported strong interim results from its phase II clinical trial of Cavatak treatment in late stag...
Singapore: Researchers in Monash University, Australia, have found prostate cancer cells that survive androgen withdrawa...
Singapore: The global pre-diabetes population is three times the size of the current diabetes patient population and the...
A radical shift in how healthcare is delivered globally is underway. Game-changing developments in sensor technologies w...
Singapore: Phylogica has received a core patent in Australia (Registration no: 2009251209; Divisional of AU 2008200790)...
Singapore: In a bid to shift its focus from technology development to sales, Australia's top medical device manufacturer...
Singapore: In a move to venture into the global market, Australia's leading healthcare logistics provider STL Warehousin...
Singapore: GI Dynamics received conditional approval from the US FDA to commence a pivotal clinical trial of the EndoBar...
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...
Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...
Singapore: Australia's Medical Research Commercialization Fund (MRCF) and the Uniseed Commercialization Fund have jointl...
Singapore: US-based Osiris Therapeutics, which develops and markets stem cell products to treat serious medical conditio...
Singapore: Medical technology company iSonea launched its first asthma management smartphone app, AsthmaSense, for iPhon...
Singapore: Bionomics Limited launched a phase I/II clinical trial of its vascular disrupting agent BNC105 in women with ...
After witnessing a turbulent year of 2009-10, the focus of Australia-based Sigma Pharmaceuticals in 2011 was restructu...
There is no reliable diagnostic blood test for ovarian cancer. The current market gold standard, CA125, is used as an ai...
Singapore: Australian National University (ANU) has granted an exclusive license to vaccine development company, BioDiem...
The Asia Pacific region, barring the developed nations of Australia and Singapore, needs "critical mass" where interdepe...
Singapore: Australian women will potentially have greater access to the only genomic test validated to predict whether p...
Singapore: Cancer Therapeutics, an Australian company focused on translating cancer biology research into novel treatmen...
Singapore: Hospira's Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered...
Singapore: Viralytics Biotech and Amgen, released top line results on its oncolytic virotherapy investigational product...
Singapore: The pharmaceuticals industry in the Asia Pacific is thriving on the back of escalating population and increa...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Phylogica, a leading Australian peptide drug discovery company, is expanding its collaboration with Janssen B...
Singapore: CSL has developed a new drug candidate that is able to prevent the development of type 2 diabetes and revers...
Asia's two leading economies, India and China are actively working on new strategies to attract money into the bioscienc...
Singapore: Australia-based QRxPharma has collaborated with Aesica Formulation Development for the world-wide promotion o...
Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting arti...
Singapore: Australia based Ascend Biopharmaceuticals has collaborated with 3M Drug Delivery Systems to evaluate 3M's Tol...
Singapore: Fovia Medical, a world leader in volume rendering technology, and Contrast Imaging, a leading Australian pro...
Singapore: Australian infectious disease therapy development company BioDiem signed an agreement with Griffith Universi...
Singapore: pSivida, a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye di...
Singapore: Australia-based contract research organization, Novotech, recently announced that it has expanded its Hong Ko...
Singapore: Cochlear has received the US Food & Drug Administration (FDA) approval for its Nucleus CI422 with Slim St...
Singapore: REVA Medical, listed with the ASX, has appointed Dr David Muller, director, Cardiac Catheterization at St Vin...
Singapore: Australia Patrys, a clinical stage biopharmaceutical company, has received approval to commence its planned P...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The Australian Institute for Bioengineering and Nanotechnology (AIBN) entered into research collaboration wit...
